Cargando…
Tennessee Pharmacists’ Opinions on Barriers and Facilitators to Initiate PrEP: A Qualitative Study
Pre-exposure prophylaxis (PrEP) is recommended to prevent the transmission of the human immunodeficiency virus (HIV). Although an effective treatment, the uptake in the United States remains low. Pharmacists are well-positioned to initiate the conversation with patients about PrEP, but few studies e...
Autores principales: | Cernasev, Alina, Walker, Crystal, Kerr, Caylin, Barenie, Rachel E., Armstrong, Drew, Golden, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323707/ https://www.ncbi.nlm.nih.gov/pubmed/35886282 http://dx.doi.org/10.3390/ijerph19148431 |
Ejemplares similares
-
Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements
por: Cernasev, Alina, et al.
Publicado: (2023) -
A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP)
por: Cernasev, Alina, et al.
Publicado: (2023) -
The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020) -
“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021) -
1293. The Next Step in PrEP: Evaluating Outcomes of a Pharmacist-Run HIV Pre-Exposure Prophylaxis (PrEP) Clinic
por: Ryan, Keenan, et al.
Publicado: (2018)